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Alcohol consumption: the good, the bad, and the indifferent 
 
MARIA PONTES FERREIRA and DARRYN WILLOUGHBY, Baylor University, 1312 S. 5th St., One Bear Place No. 
97313, Waco, TX 76798, USA 
 
 
 
Abstract     Dietary ethanol (alcohol) is the most widely consumed drug worldwide. High levels of mortality, mor-
bidity, and social malaise are associated with abuse of alcohol, and increasing numbers of women and youth are 
abusing alcohol. However, strong epidemiological data demonstrate a U- or J-shaped relationship between volume 
of alcohol consumed and all-cause mortality or disease burden. Moderate alcohol consumption is associated with a 
lower risk of all-cause mortality and disease burden than are abstinence and immoderate drinking. A brief review of 
the absorption, distribution, metabolism, and excretion of ethanol is provided with a discussion of the impact of 
gender differences. Potential mechanisms by which ethanol, ethanol metabolites, and (or) phytochemicals, as associ-
ated with different types of ethanol-containing beverages, are discussed in regards to the beneficial and detrimental 
impacts they may have on physiological system functioning and mortality or disease burden. Per capita consumption 
of ethanol-containing beverages varies across geo-political regions worldwide. A more recent research focus is the 
impact of consumption patterns on consumption volumes as they relate to disease and mortality. Certain drinking 
patterns moderate overall volume of ethanol consumption. Thus, an emerging approach to the study of alcohol con-
sumption in populations is to consider both the volume and pattern of consumption as they relate to mortality and 
disease burden. Alcohol consumption patterns among athletes are discussed; physiological implications of alcohol 
abuse in this population are outlined. Current guidelines for the consumption of alcohol are reviewed. Alcohol con-
sumption guidelines reflect the current scientific understanding of both the benefits of moderate alcohol consump-
tion and the detriments of immoderate alcohol consumption. 
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INTRODUCTION 
Dietary ethanol (ETOH) is a physiologically 
non-essential, energy-yielding (29 kJ·g–1) mole-
cule in humans, produced by the yeast-driven 
fermentation of pyruvate from plant products 
with high carbohydrate content. Trace amounts 
of ethanol, or alcohol as it is commonly called, 
are produced by the mammalian gastrointestinal 
flora and also occur naturally in some foods. The 
principal source of alcohol in the diet, however, 
is that derived from beverages processed by al-
coholic fermentation, such as beer, distilled spir-
its, and wine. 
Current conversations about ETOH range 
from the beneficial effects associated with mod-
erate intakes to the deleterious effects associated 
with excessive intakes; research investigations 
have followed similar lines of inquiry. Alcohol, 
like all drugs, can be considered both a tonic and 
a toxin; the difference apparently lies in the dose. 
Indeed, epidemiological data from more than 
100 studies across 25 countries have rather con-
sistently demonstrated that there is an inverse 
association between moderate ETOH consump-
tion and coronary heart disease (Goldberg et al. 
2001). Positive effects of alcohol or wine intake 
on several metabolic syndrome factors have been 
demonstrated in the literature, such as blood tri-
glycerides, lipoprotein profiles, and blood pres-
sure (Djousse et al. 2004), as well as on several 
cardiovascular disease risk factors such as oxida-
tive stress (Zima et al. 2001), insulin sensitivity 
and diabetes mellitus (Koppes et al. 2005), an-
thropometric parameters (Bobak et al. 2003), 
hemostasis (Booyse et al. 2007), inflammation 
(Szabo 2007), endothelial function (Hoffmeister 
et al. 2003), and cancer (McPherson 2007). 
Nationally, however, ETOH consumption is also 
accountable for high levels of mortality, morbidi-
ty, and social malaise in Canada (Adlaf et al. 
2005). Worldwide, alcohol abuse is expected to 
take an increasing toll on lives and communities. 
Consumption volumes and patterns of ETOH 
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across the world are increasingly more harmful 
and risky, and more young people and women 
are adopting these patterns (Mancinelli et al. 
2006). 
WORLDWIDE CONSUMPTION PAT-
TERNS: PER CAPITA 
Worldwide per capita consumption of pure 
ETOH by adults varies across countries (Rehm et 
al. 2003a; Rehm and Monteiro 2005). Germany, 
France, and Spain each consume over 10 L·y–1 
total across the 3 categories of alcoholic bever-
age; the USA, Canada, and Italy each consume 
more than 7 L·y–1, but less than 10 L·y–1; the Re-
public of China's per capita consumption is less 
than 6 L·y–1. The World Health Organization 
(WHO) designated Eastern Mediterranean region 
B and parts of Southeast Asia region D, includ-
ing India, demonstrate a low volume consump-
tion (1.3 L·y–1 and 2.0 L·y–1, respectively), for 
example. Worldwide average per capita con-
sumption of ETOH across the 3 categories of al-
coholic beverage is 5.8 L·y–1, a population-
weighted average value, with distilled spirits ac-
counting for the majority of the alcohol con-
sumed (Rehm et al. 2003a; Rehm and Monteiro 
2005). The highest volume of ETOH consump-
tion occurs in the established market economies   
in Western Europe and in the former socialist 
countries such as Russia and surrounding coun-
tries (12.9 L·y–1 and 13.9 L·y–1, respectively). The 
lowest volume of ETOH consumption occurs in 
pockets of the WHO designated regions, specifi-
cally in the mostly Islamic regions of Eastern 
Mediterranean D and B (0.6 L·y–1 and 1.3 L·y–1, 
respectively). 
In the Americas, the Federal Republic of 
Brazil and the countries of North America (Can-
ada, United Mexican States, and the USA) each 
consume per capita almost twice the world aver-
age at approximately 9 L·y–1, with beer providing 
the majority of the ETOH consumed (Rehm and 
Monteiro 2005). Not surprisingly, heavy drinking 
is a major cause of preventable death in these 
countries (Rehm et al. 2003b). Consumption of 
ETOH in the US is documented through alcohol 
tax records. After Prohibition in 1935, alcohol 
sales in the US slowly increased and peaked in 
the 1980s at approximately 10 L·y–1 pure ETOH 
consumed per capita. Thereafter, consumption 
declined to current levels. Consumption of 
ETOH in Canada is documented in surveys such 
as the Canadian Addiction Survey (CAS) and its 
ancestors the National Alcohol and Other Drugs 
Survey 1989 (NADS) and Canada’s Alcohol and 
Other Drugs Survey 1994 (CADS), and con-
firmed by alcohol sales records (Adlaf et al. 
2005). In Canada, the data indicate that the per-
centage of drinkers declined from 1989 to 1994, 
but has since risen to a new high in 2004, at the 
time of the CAS, a monitoring and surveillance 
initiative focused on alcohol and other drug use 
in Canada. In 2001, 7.6% and 3.5% of all deaths 
in Canada among men and women under the age 
of 70 y, respectively, could be attributed to 
ETOH (Rehm et al. 2006). Nonetheless, the re-
sults in Canada can be summarized to say that 
the protective effects of moderate ETOH con-
sumption on diabetes mellitus and cardiovascular 
outcomes outweigh the detrimental effects on 
mortality. 
The highest per capita consumption of alco-
hol in the Americas occurs in Argentina at 16.3 
L·y–1, and the lowest occurs in Trinidad and To-
bago at 2.4 L·y–1 (Rehm and Monteiro 2005). 
The Andean region of South America has a re-
gional per capita consumption of ETOH (mostly 
in the form of distilled spirits) of 5.1 L·y–1, a lev-
el slightly lower than the worldwide average. 
The mainland Central American countries also 
consume less alcohol per capita than the world-
wide average, at 4.8 L·y–1 (Rehm and Monteiro 
2005). 
ABSORPTION, DISTRIBUTION, METAB-
OLISM, AND EXCRETION 
Alcohol, consumed in the form of beverages, 
does not require mechanical or enzymatic diges-
tion in the gastrointestinal tract. The intact 
ETOH molecule!—!that which is not metabolized 
in the gastric mucosa by alcohol dehydrogenase 
(ADH)!—!is quickly and completely absorbed by 
passive diffusion in the stomach and proximal 
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small intestines, and subsequently enters the por-
tal circulation. Factors that influence the rate of 
absorption of alcohol include the presence of 
sugar (Wu et al. 2006), presence of carbonation 
(Roberts and Robinson 2007), and gastric con-
tents such as food (Gentry 2000; Levitt 2002; 
Ramchandani et al. 2001a). Although ETOH 
does not require enzymatic digestion in the gas-
trointestinal tract, a small portion of ingested 
ETOH (approximately 2%) undergoes gastric 
first-pass metabolism by gastric ADH (Levitt 
2002; Levitt et al. 1997). Gastric first-pass me-
tabolism decreases ETOH bioavailability in 
healthy young men to a greater extent than in 
healthy young women; these gender differences 
are not seen in the elderly, as gastric ADH activi-
ty in the elderly is significantly lower, especially 
in aged men (Pozzato et al. 1995). Recent ad-
vances in the study of ETOH pharmacokinetics 
using the alcohol-clamp methodology allows for 
the study of elimination kinetics independent of 
variation in alcohol absorption (Ramchandani 
and O'Connor 2006). Its application will un-
doubtedly clarify many of the determinants of 
alcohol absorption, distribution, and elimination 
in humans (Ramchandani et al. 2001b), such as 
gender differences in the expression of molecular 
forms of ADH (Baraona et al. 2001). 
The alcohol molecule is intriguing in that it is 
amphipathic; it has both lipophilic and hydro-
philic characteristics. The lipophilic qualities of 
alcohol facilitate the capacity of the molecule to 
diffuse across cell membranes. The hydrophilic 
qualities of alcohol are explained through hydro-
gen bonding. The attraction between water and 
the hydroxyl group of the alcohol molecules is 
strong enough to solubilize ETOH, but not so 
strong that alcohol is irrevocably bound to water. 
As ETOH is a small polar molecule completely 
soluble in water, its volume of distribution 
throughout the body is comparable with total 
body water (Ramchandani et al. 2001a). Thus, 
approximately 70% of the body’s mass is ETOH 
accessible (Koolman and Röhm 2005). These 
characteristics have important implications for 
both understanding physiological responses to 
ETOH, and subsequent policy-making (e.g., def-
inition of moderate drinking across genders). 
Maximal blood alcohol concentrations 
(BACs) are reached approximately 75 min post-
consumption (Jones et al. 1991). Ethanol is 
quickly distributed across all water compart-
ments of the body, which is approximately 70% 
of body mass. Therefore, BACs are dependent in 
part upon body composition. For example, as 
women generally have a lower skeletal muscle 
mass and a higher fat mass than men, BAC will 
be higher in women than in men upon consump-
tion of an equal volume of ETOH (Ramchandani 
et al. 2001a). This observation is largely due to a 
lower tissue mass in women within which ETOH 
can be diffused away from the bloodstream be-
fore hepatic metabolism. Compartmental phar-
macokinetic models for ETOH quantify alcohol 
concentrations in the body using compartments 
with combinations of zero-order kinetics, first-
order kinetics, and Michaelis–Menten kinetics. 
However, they do not quantitatively characterize 
the ETOH pharmacokinetics in terms of physio-
logically based body compartments as do the 
emerging “physiologically based pharmacokinet-
ic models” (PBPKs) (Ramchandani et al. 2001a). 
Future research should clarify the distributional 
behavior of ETOH using appropriate models to 
describe ETOH absorption, distribution, and 
elimination in the body (Ramchandani and 
O'Connor 2006). 
The primary site of ETOH metabolism is in 
the hepatocyte (Koolman and Röhm 2005). Al-
cohol dehydrogenase (ADH), a non-inducible 
cytoplasmic enzyme, oxidizes alcohol to acetal-
dehyde, capturing reducing equivalents as 
NADH + H+ by the coenzyme NAD+. This is the 
rate-limiting step in the cytoplasmic series of 
ADH reactions. Alternatively, ETOH can be oxi-
dized in the smooth endoplasmic reticulum of the 
hepatocyte by the non-specific, inducible cyto-
chrome P450 monooxygenase (MOX) (Lieber 
1997). This enzyme, which uses reducing 
equivalents from FADH2, catalyzes the hydrox-
ylation of ETOH and concomitant reduction of 
molecular oxygen to form acetaldehyde, water, 
and FADH. Monooxygenases catalyze what are 
known as phase 1 inter-conversion reactions to 
prepare polar or weakly polar substances such as 
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ETOH for renal excretion as more strongly polar 
metabolites (Koolman and Röhm 2005). 
Regardless of the path used to oxidize ETOH, 
acetaldehyde is a reactive compound even more 
toxic than alcohol (it can form covalent com-
plexes with biomolecules such as proteins and 
nucleic acids). It is oxidized in the mitochondria 
by acetaldehyde dehydrogenase using the coen-
zyme NAD+, forming acetate and NADH + H+. 
In the cytosol, acetate is converted to acetyl CoA 
by acetate CoA ligase. Acetyl CoA is a key in-
termediate in the amphibolic pathways of inter-
mediary metabolism; as such, it represents the 
site of entry of metabolic products of ETOH deg-
radation into intermediary anabolism and catabo-
lism (Koolman and Röhm 2005). 
Alcohol dehydrogenase and aldehyde dehy-
drogenase both use NAD+ as a coenzyme. As 
NAD+ is found in limited supply in the liver and 
must be regenerated, this places a limit on the 
detoxification rate to approximately one standard 
drink per hour (about 15 g ETOH). Induction of 
the MOX enzymes increases the reaction velocity 
for ETOH metabolism, but not without conse-
quence. Induction of the non-specific MOX en-
zymes will also enhance metabolism of other 
weakly polar and non-polar compounds in the 
body (Lullmann et al. 2000), potentially leading 
to situations ranging from vitamin deficiency 
(e.g., retinol), drug interactions and amplifica-
tions due to co-metabolism, and reactive oxygen 
species (ROS) formation. 
Hepatic elimination of ETOH obeys a linear 
time course (zero-order kinetics), as ADH 
achieves half-saturation at low blood alcohol 
concentrations of 0.008% (e.g., 80 mg·L–1) 
(Lullmann et al. 2000). Thus, unlike many other 
drugs that obey exponential kinetics, the amount 
of ETOH that can be metabolized by the liver per 
unit of time remains constant at BAC above 
0.02%, which represents the plateau of the reac-
tion velocity. 
Ethanol has characteristics of both a drug and 
a nutrient. A nutrient is a chemical substance that 
is used by the body to provide energy, to build or 
repair tissues, and (or) to regulate life processes, 
and is usually obtained in a food or beverage 
form (Lagua and Claudio 2004). Drugs are non-
nutritive chemical substances used for the diag-
nosis, treatment, or prevention of a disease or as 
a component of pharmacotherapy (Houghton 
Mifflin Company 2007). Ethanol is one of the 
worlds’ most widely consumed drugs. Thus, like 
all drugs, it has the potential for therapeutic and 
toxic capacities in dose-dependent fashion.  
CONSUMPTION PATTERNS: THE GOOD 
Retrospective epidemiological studies throughout 
the world have demonstrated that there is a J-
shaped relationship between intake of ETOH and 
mortality from all causes, and that there may be 
differences in the strength of this relationship 
across the 3 main categories of alcoholic bever-
ages (beer, distilled spirits, and wine) (Gronbaek 
2007). Prospective population studies, however, 
have shown that all 3 categories of alcoholic 
beverages have protective effects on mortality 
from myocardial infarction (Mukamal et al. 
2003), and that it may be a daily moderate habit 
that confers the protection, regardless of the type 
of alcoholic beverage. In general, abstainers and 
light drinkers of alcohol have a higher risk of all-
cause mortality, coronary heart disease, and can-
cer than do moderate drinkers. Compared with 
light drinkers and moderate drinkers, heavy 
drinkers have a higher risk of all-cause mortality, 
coronary heart disease, and cancer. Moderate 
drinkers demonstrate a reduced risk of peripheral 
vascular disease, myocardial infarction, ischemic 
stroke, and mortality from cardiovascular disease  
(Goldberg et al. 2001). 
Of the 3 main classes of alcoholic beverages, 
wine is commonly believed to confer the most 
protection against all-cause and coronary heart 
disease mortality. Beer is believed to confer pro-
tection equal to or at a level somewhat below that 
conferred by wine. Distilled spirits are believed 
to confer the weakest protection. However, these 
are hypotheses that remain to be conclusively 
demonstrated by the scientific process, and the 
current evidence suggests that the major protec-
tive agent appears to be ETOH itself regardless 
of source (Mukamal et al. 2003). Lifestyle fac-
tors and other confounders that contribute to 
health benefits, such as diet and exercise habits, 
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as well as socioeconomic status, must be ade-
quately accounted for in research designed to 
elucidate the effects of various alcoholic bever-
ages on health (Gronbaek 2007). 
Drugs are often delivered to the body as rela-
tively isolated chemical substances, and an ex-
ample of this would be ETOH consumed as dis-
tilled spirits (approximately 50% pure ETOH per 
volume of 100 proof liquor). Thus, distilled spir-
its are notably absent of vitamins and phyto-
chemicals commonly associated with plant foods 
and plant food products. However, drugs can also 
be delivered in a “food matrix”. Consider, for 
example, the consumption of dried herb prepara-
tions of yesteryear (the word “drug” is etymolog-
ically derived from the Old French word 
“drogue”, which means dried herb (Houghton 
Mifflin Company 2007)). Through the delivery 
of such preparations (e.g., herbal infusion), one 
hoped to obtain enough of the desired therapeutic 
molecule(s). In somewhat similar fashion, ETOH 
is usually delivered in a liquid “food matrix” 
(e.g., beer and wine) that may be rich in some 
nutrients such as vitamins, minerals, and im-
portant non-nutritive phytochemicals. Both 
ETOH and bioactive molecules, such as second-
ary phytochemicals, have been implicated in con-
ferring health benefits through disease mitigation 
when alcoholic beverages are consumed in mod-
eration. 
Oxidative stress is implicated in the patholo-
gy of many lifestyle-related diseases (Ames and 
Gold 1991; Salonen et al. 1997; Zima et al. 2001) 
such as cancer, cardiovascular disease, and dia-
betes mellitus. Oxidative stress refers to the acute 
and chronic effects of ROS and other radical 
species formed through chemical intoxication, 
radiation, and metabolism. These reactive mole-
cules are characterized by having an unstable, 
unpaired electron configuration. In the process of 
scavenging electrons to stabilize the unpaired 
electron, reactive species oxidize body proteins, 
lipids, and nucleic acids. Anti-oxidant molecules, 
either endogenous (e.g., superoxide dismutase) 
or exogenous, (e.g., vitamins C and E and phyto-
chemicals such as carotenoids), can act as protec-
tors of our biomolecules by allowing themselves 
to donate electrons to the reactive species, by 
scavenging free radicals, or through anti-
mutagenesis. Epidemiological studies demon-
strate a correlation between increased consump-
tion of antioxidant-rich, plant-derived food prod-
ucts and reduced risk of cardiovascular disease 
(Ignarro et al. 2007) and certain cancers (Wil-
liams and Hord 2005). 
Secondary phytochemicals are plant chemi-
cals that have defense, pigment, scent, color, and 
growth-regulating functions in the secondary me-
tabolism of plants. When consumed in the form 
of plant-derived foods and food products, these 
phytochemicals may continue to have bioactive 
properties that have physiological importance in 
the mammalian body. However, as we do not 
have a physiological requirement for any one of 
these thousands of plant molecules, they are non-
nutritive. These bioactive molecules are classi-
fied according to their basic structure. 
Polyphenols are among the most widely dis-
tributed and numerous of plant compounds; fla-
vanoids are the largest polyphenol sub-group 
comprising thousands of compounds. Polyphe-
nols contribute astringency and bitterness to 
foods and beverages, and are especially plentiful 
in commonly consumed erva mate (Ilex para-
guariensis), tea (Camellia sinensis), coffee 
(Coffea arabica), fruits and vegetables, and hops 
(Humulus lupulus). The average intake of poly-
phenols is ~200 mg·d–1, and the human absorp-
tion and metabolism of both free and conjugated 
forms of phenolic acids has been demonstrated 
for both foods and beverages, including beer 
(Nardini et al. 2006). 
Recently, a variety of alcoholic and non-
alcoholic beverages were assessed for polyphe-
nol content and anti-oxidant capacities (i.e., fruits, 
tea, carrots, wines (red and white), and beers (la-
ger and dark)) (Lugasi and Hovari 2003). Poly-
phenols were found most plentiful in elderberry 
juice (approximately 5700 mg·L–1), high in red 
wines and fruit juices (approximately 1000 mg·L–
1), and lower in beers and white wines (approxi-
mately 400 mg ·L–1). In vitro anti-oxidant activity 
in all tested beverages was commensurate with 
the total polyphenol content. 
There are recent claims that the in vivo anti-
oxidant capacities of beer and red wine are simi-
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lar despite different concentrations of total poly-
phenols, possibly due to superior absorption of 
the beer phenolics as compared with those in red 
wine (Kondo 2004; Nardini et al. 2006). Thus, 
although beer contains twice the antioxidant con-
tent as white wine and half that of red wine 
(Suter 2001), the red wine antioxidants may be 
larger molecules that are not as readily absorbed 
as smaller beer antioxidant molecules. Research 
shows that beer antioxidants are readily absorbed 
and bioavailable (Ghiselli et al. 2000). This hy-
pothesis regarding possible differential absorp-
tion across matrix delivery systems warrants fur-
ther investigation (Nigdikar et al. 1998). 
An alternative hypothesis worthy of explora-
tion is that the differential polyphenolic profiles 
that occur across foods and beverages (e.g., wine 
vs. beer) are responsible for the different in vitro 
and in vivo observations of anti-oxidant capaci-
ties. For example, hops are a rich source of iso-
humulones in beer (Kondo 2004), whereas red 
wine is rich in other polyphenols (e.g., resvera-
trol) as compared with those found in white wine 
(Nigdikar et al. 1998). However, it must be em-
phasized that the research evidence supporting 
the protective effects of moderate drinking on the 
heart, and against many other conditions, cannot 
be tied assuredly to particular types of alcoholic 
beverages at this time. 
Finally, this brief discussion on the known 
benefits of ETOH should make mention of the 
under-emphasized topic of the psychotherapeutic 
value of moderate alcohol consumption upon 
health. Although experts may tacitly 
acknowledge positive psychological benefits as-
sociated with moderate alcohol consumption, the 
scientific literature appears to be preoccupied 
with the ills associated with excessive drinking 
(Heath 2007). It has been pointed out that the 
majority of the ETOH literature ignores 2/3 of 
the WHO’s definition of health: “...mental and 
social well being....” (Heath 2007). This forgot-
ten dimension in alcohol research lies in striking 
contrast to the reality that ETOH has important 
social consequences in most societies by way of 
celebration, stress reduction, appetite enhance-
ment, social interaction enhancement, and feel-
ings of well-being (Peele and Brodsky 2000). 
These psychosocial aspects of the benefits of al-
cohol should be regarded and further explored 
via the scientific process as potential health bene-
fits associated with moderate ETOH consump-
tion (Meister et al. 2000). 
CONSUMPTION PATTERNS: THE BAD 
The overall consumption of alcohol (e.g., per 
capita intake) has been the typical expression of 
exposure to ETOH as it relates to disease in the 
literature (Rehm et al. 2003a; Rehm and Mon-
teiro 2005). However, there is emerging evidence 
that the pattern of drinking (e.g., drinking in 
moderation with meals; abstention, followed by 
binge drinking) moderates the impact of the 
overall consumption of alcohol (e.g., average in-
take) on disease and mortality. Increasing num-
bers of investigations are attempting to consider 
the joint impact of average ETOH intake, as well 
as pattern of drinking (of average alcohol intake) 
in epidemiological studies. 
In the 2000 WHO study on the Global Bur-
den of Disease, a continuation, refinement, and 
update of the global epidemiological study of the 
average volume of alcohol consumed as related 
to disease burden was presented (Meloni and 
Laranjeira 2004). In general, with increasing av-
erage volume of ETOH consumed, an increased 
occurrence of health problems was observed. A 
novel attempt was also made to describe by a 
summary score the patterns of global drinking, as 
related to disease burden, which are independent 
of the average volume consumed (Rehm et al. 
2003a; Rehm and Monteiro 2005). That is to say, 
two countries that present with a similar adult per 
capita consumption of ETOH may present with 
different burdens of disease outcomes due to dif-
ferent patterns of alcohol consumption. Although 
the process of qualifiying and quantifiying risk 
relations between ETOH consumption and dis-
ease as affected by consumption pattern is a 
work in progress, some illuminating and alarm-
ing statistics emerged from the effort. 
Through the use of key informant surveys on 
WHO regions, available survey data, and factor 
analysis, countries were classified into four (1, 2, 
3, 4) score categories reflecting the risk for mor-
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tality and burden of disease associated with dif-
ferent volumes of ETOH intake, as follows: 1, 
least-risky drinking pattern (characterized by 
light to moderate drinking with meals and with-
out irregular heavy drinking bouts, and associat-
ed with a lower burden of disease and mortality); 
4, most-risky drinking pattern (characterized by 
the highest level of irregular drinking, and asso-
ciated with a higher burden of disease and mor-
tality) (Rehm and Monteiro 2005). Although not 
specifically quantified, the least-risky patterns (1, 
2) were associated with the drinking of more 
wine and beer, whereas the most-risky patterns 
(3, 4) were associated with the drinking of more 
distilled spirits. 
As detailed earlier, the volume of ETOH 
consumed was found to be highest in Western 
Europe, the former Socialist economies in East-
ern Europe, and in North America. The lowest 
volume of consumption was observed in parts of 
Southeast Asia and the Eastern Mediterranean 
region. However, when considering the drinking 
pattern scores of individual countries and (or) 
geopolitical regions, it was found that a drinking 
pattern score of 1 was only found in Europe, 
Australia, and Japan (Rehm et al. 2003a; Rehm 
and Monteiro 2005), such that no American 
country had a drinking pattern score of 1. In the 
Americas, the only countries with a drinking pat-
tern score of 2 were Canada, the USA, Argentina, 
and the Caribbean countries. Other regional 
countries with an average score of 2 include the 
predominantly Muslim countries of Iran and 
Saudi Arabia, and countries of the Western Pa-
cific region such as China, Philippines, and Viet 
Nam. 
In the Americas, the Central American coun-
tries most frequently had a drinking pattern score 
of 4 (Belize, El Salvador, Guatemala, Honduras, 
Nicaragua, and also Mexico from North Ameri-
ca), and many countries in Central and South 
America have a drinking pattern score of 3 (Bo-
livia, Brazil, Chile, Colombia, Costa Rica, Ecua-
dor, Guyana, Paraguay, Peru, Suriname, Uruguay, 
and Venezuela) (Rehm and Monteiro 2005). 
Other WHO regions with an average drinking 
pattern score of 3 or greater include countries of 
Africa E (e.g., Ethiopia, South Africa), Europe B 
(e.g., Bulgaria, Poland, Turkey), Europe C (e.g., 
Russian Federation, Ukraine), America B (e.g., 
Brazil) (Meloni and Laranjeira 2004), and South-
east Asia D (e.g., Bangladesh, India) (Rehm et al. 
2003a; Rehm and Monteiro 2005). Thus, in Gua-
temala and Nicaragua (for example), an 
isovolumic intake of ETOH is related to a greater 
burden of disease and mortality than in the other 
American countries, as per the inherent charac-
teristics of the drinking pattern score of 4 (Rehm 
et al. 2003a; Rehm and Monteiro 2005). 
Alcohol has been found to be a major risk 
factor for disease burden throughout the world. 
In the Americas, lifestyle-related risk factors 
predominated; ETOH was found to be the risk 
factor that confers the greatest burden of disease, 
followed by smoking, and then by under-
nutrition (when broken down into American sub-
regions, smoking is the first risk factor that con-
fers the greatest burden of disease in Anglophone 
North America (Canada and the US)). Thus, pre-
vention interventions are warranted that address 
the overall volume of ETOH consumption (de-
crease to a moderate intake), the consumption 
pattern should be addressed (decrease irregular 
bouts of heavy drinking and, if alcohol is con-
sumed, it should be consumed in moderation and 
with meals) and perhaps also the types of alco-
holic beverages chosen. It has been demonstrated 
that among females, the primary determinant of 
the inverse association between drinking ETOH 
and risk of heart disease may be the simple in-
take of alcohol, and not the frequency of con-
sumption (Tolstrup et al. 2006). Among the men 
studied, the frequency of ETOH appears to be 
more important; specifically, the lowest risk of 
coronary heart disease was observed among the 
men who drank daily (Tolstrup et al. 2006). 
ALCOHOL AND ATHLETICS: CON-
SUMPTION PATTERNS AND HEALTH 
AND PERFORMANCE ISSUES 
Alcohol has also been found to be a major health 
risk among athletes and habitual exercisers, as 
ETOH is the most frequently consumed drug in 
this population. Alcohol abuse is one of the big-
gest problems on college and university campus-
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es (El-Sayed et al. 2005). It is currently recog-
nized that the abuse of ETOH among university 
students is a public health concern, and that in-
tercollegiate athletics is recognized to be a sub-
population of the campus community at higher 
risk for excessive drinking practices specifically 
(Martens et al. 2006), and immoderate drinking 
practices generally. In the arena of one of the 
world’s most popular sports, football (soccer), it 
is not currently clear if the volume and pattern of 
ETOH consumption among footballers differs 
from that of other competitive athletes. However, 
it is clear that footballers engage in binge drink-
ing, as do other athletes (Maughan 2006). Binge 
drinking is defined by the International Center 
for Alcohol Policies as the consumption of 5+ 
standard drinks on one occasion (of unspecified 
duration) by men or 4+ standard drinks on one 
occasion (of unspecified duration) by women 
(International Center for Alcohol Policies 2003). 
The general health and performance consequenc-
es of immoderate drinking have some ramifica-
tions of special concern to athletes. 
Dietary ETOH, with a density of 0.79 g/mL, 
is an energy-yielding molecule without require-
ment by mammalian physiology. Alcohol has a 
high energy density at 29 kJ·g–1, and can readily 
displace nutrient-dense foods in the diet while 
contributing excess dietary energy. This can im-
pact energy balance, as well as macronutrient 
balance in the body, potentially interfering with 
glycogen re-synthesis through displacement of 
carbohydrate in the diet and non-adherence to 
sport nutrition guidelines (El-Sayed et al. 2005; 
Shirreffs and Maughan 2006) 
Micronutrients (vitamins and minerals) are 
displaced along with the dietary intake of foods 
when excess ETOH is consumed; additionally, 
the requirements for certain micronutrients are 
likely increased through the metabolism of alco-
hol (van den Berg et al. 2002). Hepatic metabo-
lism of ETOH requires increased use of the 
NAD+ and FAD cofactors of several enzymes 
used in alcohol metabolism (of which vitamins 
B3 and B2 are components, respectively), as well 
as vitamins B1 (used in pyruvate dehydrogenase 
reaction), B5 (a component of acetyl CoA, which 
accumulates and leads to increased fatty acid 
synthesis), and B6 (involved in transamination 
reactions and glycogenolysis). 
Ethanol is a drug capable of producing toxic 
effects in a dose-dependent manner, especially 
when taken in doses greater than what the liver 
can process per hour (approximately 15 g ETOH). 
The implications of the toxic chemical effects of 
ETOH and acetaldehyde can be considered from 
the moment of ingestion or production upon all 
points of contact with body tissues thereafter (un-
til metabolism). For example, alterations in mu-
cosal lining in the gastrointestinal tract due to 
chemical damage can subsequently lead to mal-
absorption of nutrients (Rajendram and Preedy 
2005). Another example is that the toxic effects 
of alcohol and acetaldehyde may partially ex-
plain the atrophy of types I, IIa, and IIb myofi-
bers, decreased capillarity, and altered metabo-
lism observed in skeletal muscle tissue in exer-
cisers (El-Sayed et al. 2005). 
ROS, such as the hydroxyl radical, are known 
to be generated in response to ETOH and acetal-
dehyde metabolism (Dahchour et al. 2005). Oxi-
dative stress occurs when there is an imbalance 
between anti-oxidant defense systems and the 
production of ROS. Metabolism of ETOH gener-
ates ROS both in the mitochondrial electron 
transport chain and by MOX (Albano 2006), and 
oxidative stress is attributed to alcoholic liver 
disease (Albano 2006) and alcohol myopathy 
(Lang et al. 2005). Thus, several metal co-factors 
(e.g., zinc, manganese, copper, iron, and seleni-
um) likely have increased rates of recycling ow-
ing to up-regulation of endogenous anti-oxidant 
systems such as superoxide dismutase, catalase, 
and glutathione peroxidase in response to alcohol 
metabolism-derived production of ROS such as 
the hydroxyl radical. Exogenous anti-oxidants, 
such as vitamin E (particularly in the central 
nervous system), vitamin C, and β-carotene may 
also require dietary attention due to increased use 
in the face of alcohol-induced oxidative stress. 
Immoderate intakes of alcohol exceed the ca-
pacity of the ADH system to metabolize ETOH, 
leading to hepatic MOX induction. Exercise per-
formance also enhances the metabolism of 
ETOH by the microsomal system (El-Sayed et al. 
2005). These observations should raise a red flag 
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regarding the potential for oxidative stress due to 
both exercise and ETOH consumption (both 
chemically induced and as a result of ROS for-
mation). However, it has also been shown that 
exercise training mitigates alcohol-induced oxi-
dative damage (El-Sayed et al. 2005), suggesting 
a need for further research in this area. 
Ethanol provides a powerful diuresis effect 
that is well recognized; it acts as a diuretic via 
suppression of the release of anti-diuretic hor-
mone from the pituitary. This presents important 
considerations for athletes who either consume 
alcohol in moderate or immoderate doses. It has 
been estimated that the kidney will produce ex-
cess urine on the order of 10 mL/g ETOH ingest-
ed (Shirreffs and Maughan 2006). So, one drink 
of approximately 14 g ETOH will result in diure-
sis of 140 mL urine above and beyond normal 
output. This can lead to negative hydration bal-
ance. 
Other notable effects of ETOH include ef-
fects upon the thermoregulatory system and on 
wake–sleep patterns. Ethanol depresses the ther-
moregulatory center in the brain, allowing cool-
ing of the body to dangerous levels if the ambient 
temperature is sufficiently low (Shirreffs and 
Maughan 2006). Sedating substances such as 
ETOH can lead to daytime periods of sleepiness 
and interrupt the nocturnal sleep period (Roehrs 
and Roth 2001), especially if the person is taking 
other medications that have a synergistic interac-
tion with ETOH. 
Gender differences in alcohol consumption 
and metabolism are important to mention, as they 
may relate to exercise. The overall burden of dis-
ease and injury due to ETOH consumption is less 
in women than in men both throughout the world 
(15.3%) and in the Americas (16.7%) (Rehm and 
Monteiro 2005). This may be explained, in part, 
as a result of the overall significant gender dif-
ferences in the proportion of drinkers throughout 
the world. Only in the WHO regions Europe A, 
Europe C, and Western Pacific A are the propor-
tion of female drinkers within 10% of the propor-
tion of male drinkers (Rehm et al. 2003a; Rehm 
and Monteiro 2005). In anglophone North Amer-
ica (e.g., Canada, the US), the proportion of fe-
male drinkers is within 15% of the proportion of 
male drinkers, as compared with 22% of the 
WHO region Americas B (e.g., Brazil, Mexico). 
Women’s consumption rate and pattern of im-
moderate ETOH intake is rapidly increasing, 
both in the Americas and throughout the world 
(Mancinelli et al. 2006). The age of first use is 
dramatically decreasing, and the drinking rate 
among female teenagers is quite similar to the 
drinking rate of their male peers (Mancinelli et al. 
2006). 
In a systematic review of college student–
athlete drinking, it has been reported that the 
prevalence rates of ETOH consumption were 
consistently lower among female athletes than 
among male athletes (Martens et al. 2006). How-
ever, it was also reported that drinking rates were 
consistently higher among female athletes than 
among female non-athletes across the following 
categories: heavy episodic drinking in the past 2 
weeks, frequent heavy episodic drinking in the 
past 2 weeks, and number of drinks per week 
(Martens et al. 2006). The brief discussion pro-
vided earlier regarding female metabolism of 
ETOH highlighted gender differences in BAC 
due to body composition and gender differences 
in gastric first-pass metabolism (Frezza et al. 
1990). Additionally, there are also suggested 
gender differences in ADH activity, effects of 
hormonal profiles on ETOH metabolism, and 
other gender differences related to ETOH metab-
olism that warrant further research (Mancinelli et 
al. 2006; Muller 2006). Especially notable is the 
relative paucity of alcohol-related research in 
female athletes, given the clear indication of the 
rising rates of use and abuse in this population 
and the aforementioned gender differences in 
metabolism. 
Although discussing the acute effects of ex-
cess ETOH consumption are outside the scope of 
this review, it is important to at least comment 
upon the possible aftereffects of immoderate and 
binge drinking on next-day training and practice 
endeavors by athletes. First, it has been docu-
mented that BAC can remain above the legal 
limit of driving a car the morning after a binge-
drinking bout (Maughan 2006). This would result 
in an athlete showing up for practice or a game 
still under the influence of alcohol. Alternatively, 
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BAC may have returned to normal the day after 
the binge drinking bout, but the athlete may pre-
sent with a hangover at practice or competition. 
The symptoms of hangovers are believed to be 
due to dehydration, aberrations in acid–base bal-
ance, macronutrient metabolism disruption, car-
diovascular changes (increased heart rate, de-
creased left ventricular performance, and in-
creased blood pressure), and immune defense 
suppression (Maughan 2006). Any of the above 
possible aftereffects of excess alcohol consump-
tion are sufficient to merit discouragement of 
immoderate ETOH use by athletes for health and 
performance reasons. The reader is referred to 
the American College of Sports Medicine (1982) 
position stand on the use of alcohol in sports for 
an older, comprehensive review on the topic. 
MODERATE CONSUMPTION GUIDE-
LINES 
The International Center for Alcohol Policies 
(ICAP) has compiled international guidelines for 
ETOH consumption. These are guidelines de-
signed to alter alcohol consumption behavior in 
target populations. The reader is referred to 
ICAP report 14 for the compendium (Interna-
tional Center for Alcohol Policies 2003). It is 
noteworthy that the recommendations across 
many countries are quite disparate, despite the 
readily available current scientific literature. This 
may be partly attributable to differences in in-
tended outcome: decrease ETOH misuse vs. 
promote moderate use (Harding and Stockley 
2007). 
In Canada, the Centre for Addiction and 
Mental Health defines a standard alcoholic drink 
as one containing 13.6 g ETOH. Women and 
men are both advised not to exceed 27.2 g·d–1 
ETOH (2 standard drinks). In the US, one stand-
ard drink is considered to provide on average 14 
g ETOH: 355 mL (12 fl. oz) beer, 150 mL (5 fl. 
oz) wine, or 45 mL (1 fl. oz) distilled spirits. Ac-
cording to the United States Department of Agri-
culture (USDA) and the Department of Health 
and Human Services (DHHS) in the US, women 
should consume no more than one standard drink 
per day, and men should consume no more than 
two standard drinks per day. 
SUMMARY 
Current literature shows both the promise and 
peril of alcohol consumption; it appears that the 
tonic becomes a toxin in a dose-dependent fash-
ion. The balancing act is perturbed by alarming 
statistics demonstrating the devastating potential 
of one the world’s most consumed drugs in ex-
cess!—!especially among the young, women, and 
athletes!—!and is assuaged by statistics demon-
strating reduced risk of all-cause mortality and 
coronary heart disease mortality among moderate 
drinkers. It is important to have a clear under-
standing of both the benefits and risks of ETOH 
consumption. It is imperative to communicate 
our current understanding of the scientific litera-
ture on alcohol research to our target populations. 
We can do this through refinement and promul-
gation of the official guidelines for the moderate 
consumption of alcoholic beverages. In so doing, 
we can provide both individuals and populations 
with a consistent message for guidance regarding 
the use of ETOH that is reflective of the evidence 
regarding both the detrimental effects of exces-
sive consumption and the beneficial effects of 
moderate consumption. 
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